vs
Bluerock Homes Trust, Inc.（BHM）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Bluerock Homes Trust, Inc.的1.9倍（$35.5M vs $18.9M），Bluerock Homes Trust, Inc.净利率更高（-50.1% vs -304.2%，领先254.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 35.9%），Bluerock Homes Trust, Inc.自由现金流更多（$10.4M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 30.1%）
Bluerock Homes Trust, Inc.是一家总部位于美国的房地产投资信托企业，主要收购、持有并运营优质单户住宅租赁资产，面向美国高增长郊区市场的中等收入租户，聚焦人口基本面向好、租赁需求旺盛的区域布局。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BHM vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.9M | $35.5M |
| 净利润 | $-9.5M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -48.8% | -304.8% |
| 净利率 | -50.1% | -304.2% |
| 营收同比 | 35.9% | 681.7% |
| 净利润同比 | -29.9% | 39.6% |
| 每股收益（稀释后） | $-0.75 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $18.9M | $35.5M | ||
| Q3 25 | $16.6M | $5.2M | ||
| Q2 25 | $16.8M | $19.2M | ||
| Q1 25 | $16.4M | $14.7M | ||
| Q4 24 | $13.9M | $4.5M | ||
| Q3 24 | $12.7M | $26.1M | ||
| Q2 24 | $12.5M | $14.4M | ||
| Q1 24 | $11.2M | $13.8M |
| Q4 25 | $-9.5M | $-108.1M | ||
| Q3 25 | $-10.0M | $-162.3M | ||
| Q2 25 | $-5.8M | $-171.9M | ||
| Q1 25 | $-7.3M | $-202.5M | ||
| Q4 24 | $-7.3M | $-178.9M | ||
| Q3 24 | $3.5M | $-95.8M | ||
| Q2 24 | $-5.2M | $-97.5M | ||
| Q1 24 | $-3.2M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -48.8% | -304.8% | ||
| Q3 25 | -57.6% | -3327.6% | ||
| Q2 25 | -30.9% | -916.8% | ||
| Q1 25 | -42.6% | -1297.9% | ||
| Q4 24 | -52.8% | -4042.4% | ||
| Q3 24 | 27.9% | -377.1% | ||
| Q2 24 | -41.3% | -697.4% | ||
| Q1 24 | -28.4% | -698.4% |
| Q4 25 | -50.1% | -304.2% | ||
| Q3 25 | -60.0% | -3135.3% | ||
| Q2 25 | -34.7% | -894.2% | ||
| Q1 25 | -44.7% | -1373.3% | ||
| Q4 24 | -52.8% | -3935.5% | ||
| Q3 24 | 27.9% | -367.5% | ||
| Q2 24 | -41.3% | -676.6% | ||
| Q1 24 | -28.4% | -662.4% |
| Q4 25 | $-0.75 | $-0.17 | ||
| Q3 25 | $-0.94 | $-0.36 | ||
| Q2 25 | $-0.66 | $-0.41 | ||
| Q1 25 | $-0.67 | $-0.50 | ||
| Q4 24 | $-0.65 | $-0.56 | ||
| Q3 24 | $0.24 | $-0.34 | ||
| Q2 24 | $-0.42 | $-0.40 | ||
| Q1 24 | $-0.27 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $169.6M | $743.3M |
| 总债务越低越好 | $428.4M | $9.6M |
| 股东权益账面价值 | $128.7M | $1.1B |
| 总资产 | $1.2B | $1.5B |
| 负债/权益比越低杠杆越低 | 3.33× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $169.6M | $743.3M | ||
| Q3 25 | $2.1M | $659.8M | ||
| Q2 25 | $4.2M | $525.1M | ||
| Q1 25 | $3.0M | $500.5M | ||
| Q4 24 | $115.2M | $594.4M | ||
| Q3 24 | $155.1M | $427.6M | ||
| Q2 24 | $116.0M | $474.3M | ||
| Q1 24 | $92.3M | $296.3M |
| Q4 25 | $428.4M | $9.6M | ||
| Q3 25 | $415.9M | $11.9M | ||
| Q2 25 | $338.6M | $14.2M | ||
| Q1 25 | $336.5M | $16.4M | ||
| Q4 24 | $373.8M | $19.0M | ||
| Q3 24 | $122.5M | $20.5M | ||
| Q2 24 | $119.7M | $22.9M | ||
| Q1 24 | $120.2M | — |
| Q4 25 | $128.7M | $1.1B | ||
| Q3 25 | $131.7M | $1.0B | ||
| Q2 25 | $135.3M | $919.1M | ||
| Q1 25 | $137.1M | $933.9M | ||
| Q4 24 | $139.1M | $1.0B | ||
| Q3 24 | $142.9M | $524.6M | ||
| Q2 24 | $142.5M | $584.4M | ||
| Q1 24 | $144.5M | $401.2M |
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $222.1M | $1.4B | ||
| Q2 25 | $220.3M | $1.3B | ||
| Q1 25 | $186.2M | $1.3B | ||
| Q4 24 | $967.0M | $1.4B | ||
| Q3 24 | $800.8M | $726.5M | ||
| Q2 24 | $756.2M | $775.9M | ||
| Q1 24 | $727.4M | $557.8M |
| Q4 25 | 3.33× | 0.01× | ||
| Q3 25 | 3.16× | 0.01× | ||
| Q2 25 | 2.50× | 0.02× | ||
| Q1 25 | 2.45× | 0.02× | ||
| Q4 24 | 2.69× | 0.02× | ||
| Q3 24 | 0.86× | 0.04× | ||
| Q2 24 | 0.84× | 0.04× | ||
| Q1 24 | 0.83× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $10.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | 55.0% | -133.1% |
| 资本支出强度资本支出/营收 | 91.8% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $25.0M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $27.8M | $-46.1M | ||
| Q3 25 | $13.4M | $-117.4M | ||
| Q2 25 | $13.9M | $-76.4M | ||
| Q1 25 | $951.0K | $-132.0M | ||
| Q4 24 | $9.1M | $-115.4M | ||
| Q3 24 | $1.7M | $-59.2M | ||
| Q2 24 | $1.3M | $-82.2M | ||
| Q1 24 | $1.1M | $-102.3M |
| Q4 25 | $10.4M | $-47.3M | ||
| Q3 25 | $8.7M | $-117.6M | ||
| Q2 25 | $8.8M | $-79.6M | ||
| Q1 25 | $-2.9M | $-133.8M | ||
| Q4 24 | $-253.0K | $-116.7M | ||
| Q3 24 | $-601.0K | $-63.8M | ||
| Q2 24 | $-654.0K | $-83.4M | ||
| Q1 24 | $-630.0K | $-109.0M |
| Q4 25 | 55.0% | -133.1% | ||
| Q3 25 | 52.4% | -2272.5% | ||
| Q2 25 | 52.2% | -413.9% | ||
| Q1 25 | -17.6% | -907.4% | ||
| Q4 24 | -1.8% | -2567.7% | ||
| Q3 24 | -4.7% | -244.6% | ||
| Q2 24 | -5.2% | -578.5% | ||
| Q1 24 | -5.6% | -789.9% |
| Q4 25 | 91.8% | 3.5% | ||
| Q3 25 | 28.5% | 4.7% | ||
| Q2 25 | 30.3% | 16.4% | ||
| Q1 25 | 23.4% | 12.4% | ||
| Q4 24 | 66.9% | 28.6% | ||
| Q3 24 | 18.0% | 17.5% | ||
| Q2 24 | 15.3% | 8.2% | ||
| Q1 24 | 15.5% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BHM
| Residential Communities Segment | $11.4M | 61% |
| Scattered Single Family Homes Segment | $7.5M | 39% |
RXRX
暂无分部数据
